123
- Liang Y, Ganem D (2003) Lytic but not latent infection by Kaposi’s sarcoma-associated her-
pesvirus requires host CSL protein, the mediator of notch signaling. Proc Natl Acad Sci U S
A 100(14):8490–8495 - Li S et al (2016) Fine-tuning of the Kaposi’s sarcoma-associated herpesvirus life cycle in
neighboring cells through the RTA-JAG1-notch pathway. PLoS Pathog 12(10):e1005900 - Dittmer DP, Damania B (2013) Kaposi sarcoma associated herpesvirus pathogenesis
(KSHV)--an update. Curr Opin Virol 3(3):238–244 - Li Q et al (2008) Genetic disruption of KSHV major latent nuclear antigen LANA enhances
viral lytic transcriptional program. Virology 379(2):234–244 - Yoo J et al (2012) Opposing regulation of PROX1 by interleukin-3 receptor and NOTCH
directs differential host cell fate reprogramming by Kaposi sarcoma herpes virus. PLoS
Pathog 8(6):e1002770 - Cheng F et al (2011) KSHV-initiated notch activation leads to membrane-type-1 matrix
metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition. Cell Host
Microbe 10(6):577–590 - Staskus KA et al (1997) Kaposi’s sarcoma-associated herpesvirus gene expression in endo-
thelial (spindle) tumor cells. J Virol 71(1):715–719 - Boshoff C et al (1995) Kaposi’s sarcoma-associated herpesvirus infects endothelial and spin-
dle cells. Nat Med 1(12):1274–1278 - Jussila L et al (1998) Lymphatic endothelium and Kaposi’s sarcoma spindle cells detected
by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res
58(8):1599–1604 - Wang HW et al (2004) Kaposi sarcoma herpesvirus-induced cellular reprogramming
contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet
36(7):687–693 - Kahn HJ, Bailey D, Marks A (2002) Monoclonal antibody D2-40, a new marker of lym-
phatic endothelium, reacts with Kaposi’s sarcoma and a subset of angiosarcomas. Mod Pathol
15(4):434–440 - Pyakurel P et al (2006) Lymphatic and vascular origin of Kaposi’s sarcoma spindle cells dur-
ing tumor development. Int J Cancer 119(6):1262–1267 - Hong YK et al (2004) Lymphatic reprogramming of blood vascular endothelium by Kaposi
sarcoma-associated herpesvirus. Nat Genet 36(7):683–685 - Carroll PA, Brazeau E, Lagunoff M (2004) Kaposi’s sarcoma-associated herpesvirus infec-
tion of blood endothelial cells induces lymphatic differentiation. Virology 328(1):7–18 - Kaaya EE et al (1995) Heterogeneity of spindle cells in Kaposi’s sarcoma: comparison of
cells in lesions and in culture. J Acquir Immune Defic Syndr Hum Retrovirol 10(3):295–305 - Ciufo DM et al (2001) Spindle cell conversion by Kaposi’s sarcoma-associated herpesvirus:
formation of colonies and plaques with mixed lytic and latent gene expression in infected
primary dermal microvascular endothelial cell cultures. J Virol 75(12):5614–5626 - Abere B, Schulz TF (2016) KSHV non-structural membrane proteins involved in the activa-
tion of intracellular signaling pathways and the pathogenesis of Kaposi’s sarcoma. Curr Opin
Virol 20:11–19 - Abboud ER et al (2013) Kaposi sarcoma-associated herpesvirus g protein-coupled receptor
enhances endothelial cell survival in part by upregulation of bcl-2. Ochsner J 13(1):66–75 - Sadagopan S et al (2009) Kaposi’s sarcoma-associated herpesvirus upregulates angio-
genin during infection of human dermal microvascular endothelial cells, which induces
45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis. J Virol
83(7):3342–3364 - Raggo C et al (2005) Novel cellular genes essential for transformation of endothelial cells by
Kaposi’s sarcoma-associated herpesvirus. Cancer Res 65(12):5084–5095 - Flore O et al (1998) Transformation of primary human endothelial cells by Kaposi’s sarcoma-
associated herpesvirus. Nature 394(6693):588–592 - Lagunoff M et al (2002) De novo infection and serial transmission of Kaposi’s sarcoma-
associated herpesvirus in cultured endothelial cells. J Virol 76(5):2440–2448
7 KSHV Epidemiology and Molecular Biology